Investigation: Facebook and Instagram Still Running Ads for Illegal Drugs

The volume of drugs ads on Meta's platforms reportedly violates the company's own policies, as well as US law.

Meta ran more than 450 paid advertisements across its platforms – including Facebook and Instagram – in a mere 15 weeks for the sale of prescription and recreational drugs, according to a new investigation.

That’s despite Mark Zuckerberg’s company joining the Alliance to Prevent Drug Harms in March and, at the same time, pledging to “disrupt the sale of synthetic drugs online.”

In addition to ads on Instagram and Facebook for highly addictive opioids such as codeine and OxyContin, the research also surfaced posts appearing to market recreational drugs MDMA and ecstasy.

452 Ads for Drugs

The investigation was carried out by the Tech Transparency Project (TTP) – a research initiative that “seeks to hold large technology companies accountable.”

It searched for ads selling drugs on Meta’s platforms in the 15 weeks from March 1st this year, specifically searching for terms such as ‘OxyContin,’ ‘Xanax,’ ‘codeine’ and ‘pure coke.’ It also looked for ad content that included the terms ‘WhatsApp’ and ‘t.me’ (i.e. Telegram), on the basis that the encrypted messaging apps are often used by online drug dealers looking to protect their identities.

About Tech.co Video Thumbnail Showing Lead Writer Conor Cawley Smiling Next to Tech.co Logo🔎 Looking for growth? This just in -
the top business tech deals of 2024.👨‍💻
See the list button

Over the course of that period, TTP identified a total of 452 ads for drugs across Meta’s Instagram, Facebook, Messenger and Audience Network platforms. 405 were discovered on Instagram.

The reach of those combined ads, TTP says, amounts to in excess of 2.5 million users.

However, the organization estimates that this is only a fraction of the total ads – and thus users reached – with the limitations of Meta’s Ad Library meaning it was unable to capture further examples.

Meta Violating Its Own Policies

The research findings are an embarrassment for Meta and its President of Global Affairs, Nick Clegg, after he announced on March 15th that the company had joined the Alliance to Prevent Drug Harms.

In a post on X, formerly Twitter, he branded the “opioid epidemic as a major public health issue that requires action from all parts of US society.”

He also announced that the company would join up with the Department of State, UN Office on Drugs & Crime, and Snapchat to “help disrupt the sale of synthetic drugs online + educate users about the risks.”

The volume of drugs ads still proliferating on Meta’s platforms violates the company’s own policies as well as US law, TTP says. They’re in breach, for example, of Facebook’s Community Standards to prevent the attempt to sell high-risk and non-medicinal drugs.

“Ads must not promote the sale or use of illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion.” – Meta Advertising Standards

Recreational Drugs and Unsafe Substances

The TTP includes various examples of the different kinds of ads that it discovered during its investigation, including one that clearly shows a images of OxyContin and Xanax packages.

In another, there are piles of brightly coloured pills and crystals with the words ‘MDMA’ and ‘Ecstasy’ next to them.

“The presence of these ads on Meta platforms raises questions about statements by Meta executives about how the company is doing its utmost to keep users safe.” – Tech Transparency Project

While an ad purporting to be from ‘A2X Pharmacy’ markets a range of drugs – including Oxy, Xanax, Fentanyl – offers a 50% discount and free, overnight delivery.

Did you find this article helpful? Click on one of the following buttons
We're so happy you liked! Get more delivered to your inbox just like it.

We're sorry this article didn't help you today – we welcome feedback, so if there's any way you feel we could improve our content, please email us at contact@tech.co

Written by:
Now a freelance writer, Adam is a journalist with over 10 years experience – getting his start at UK consumer publication Which?, before working across titles such as TechRadar, Tom's Guide and What Hi-Fi with Future Plc. From VPNs and antivirus software to cricket and film, investigations and research to reviews and how-to guides; Adam brings a vast array of experience and interests to his writing.
Explore More See all news
Back to top
close Building a Website? We've tested and rated Wix as the best website builder you can choose – try it yourself for free Try Wix today